Taiho Oncology Europe

Taiho Oncology Europe is the European subsidiary of Taiho Pharmaceutical Co., Ltd., a Japanese specialty pharmaceutical company focused on oncology. The company is dedicated to developing and commercializing innovative cancer therapies, particularly oral chemotherapy and targeted agents, to address unmet medical needs across Europe. Its commercial portfolio includes treatments for metastatic colorectal cancer, gastric cancer, and FGFR2-fusion positive cholangiocarcinoma. Headquartered in Zug, Switzerland, with a major operational hub in Munich, Germany, the company manages clinical development, medical affairs, and commercial operations within the European region. Taiho Oncology Europe works in close collaboration with its global counterparts and partners to expand the reach of its oncology pipeline.